Unexpected dramatic increase in CD4+ cell count in a patient with AIDS after enfuvirtide treatment despite persistent viremia and resistance mutations-Reference-Cited by-同舟云学术

Unexpected dramatic increase in CD4+ cell count in a patient with AIDS after enfuvirtide treatment despite persistent viremia and resistance mutations

Published:2008 Issue:6 Volume:80 Page:937-941
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Soria Alessandro,Cavarelli Mariangela,Sala Stefania,Alessandrini Anna Ida,Scarlatti Gabriella,Lazzarin Adriano,Castagna Antonella

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference24 articles.

1. Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment

2. Genotypic Changes in Human Immunodeficiency Virus Type 1 Protease Associated with Reduced Susceptibility and Virologic Response to the Protease Inhibitor Tipranavir

3. Expression of CD4 on human peripheral blood neutrophils

4. First-line use of enfuvirtide-containing HAART regimen with dramatic clinical and immunological improvement in three cases

5. Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-1 Entry Inhibitor Resistance;Handbook of Antimicrobial Resistance;2017

2. Combined Action of Anti-CD4 Autoantibodies and Rheumatoid Factor in the Development of CD4 Lymphocytopenia in Rats Immunized with HIV-1 gp120;AIDS Research and Human Retroviruses;2016-12

3. Resistance against inhibitors of HIV-1 entry into target cells;Future Virology;2015-02

4. HIV-1 Entry Inhibitor Resistance;Handbook of Antimicrobial Resistance;2014

5. Entry inhibitors and their use in the treatment of HIV-1 infection;Antiviral Research;2013-05